510(k) Report

510(k) · Cleared

Cleared

Artemis, Artemis TPO, Artemis MX

K222222510(k) TraditionalCleared Oct 12, 2023444-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Eigen · QTZ Radiological Image Processing Software For Ablation Therapy Planning And Evaluation

Cleared on Oct 12, 2023 as substantially equivalent to K162474 (Eigen, 2016) and 1 other predicate after a 444-day review. Its family tree reaches back 7 generations to 1996.

Decided
Oct 12, 2023
Review
444 days
Class
Class II
Product code
QTZ
Recalls
None
Predicates
2

Its longest line of descent runs back 7 generations to K954678 (1996). 12 ancestors in all, the oldest K953259 (1995). No later device cites it as a predicate yet.

  1. Root · 7 generations backK954678 Pro VisionAlgotec Systems, Ltd. · 1996
  2. 6 generations backK980648 Pro VisionAlgotec Systems, Ltd. · 1998
  3. 5 generations backK992654 Plug 'N View 3D, Version 1.0Voxar Limited · 1999
  4. 4 generations backK063107 3DNET SuiteBiotronics3D, Ltd. · 2006
  5. 3 generations backK081093 3-D Imaging WorkstationEigen, LLC · 2008
  6. 2 generations backK153073 UroNav (Version 2.0)Invivo Corporation · 2015
  7. 1 generation backK162474 ArtemisEigen · 2016
  8. This deviceK222222 Artemis, Artemis TPO, Artemis MXEigen · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K954678Pro VisionAlgotec Systems, Ltd.1996—
−6K980648Pro VisionAlgotec Systems, Ltd.1998—
−5K992654Plug 'N View 3D, Version 1.0Voxar Limited1999—
−4K0631073DNET SuiteBiotronics3D, Ltd.2006—
−3K0810933-D Imaging WorkstationEigen, LLC2008—
−2K153073UroNav (Version 2.0)Invivo Corporation2015—
−1K162474ArtemisEigen2016—
0 (this device)K222222Artemis, Artemis TPO, Artemis MXEigen2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199510
199610
200010
200310
200510
FIG. 1 — Lineage of K222222, 1996–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QTZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QTZ device

  1. #1 K252947 HistoSonics® Planning Toolscore 14.4 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K162474Artemis
Summary page 4
…redicate Devices: Device Name 510(k) Number Type Artemis K162474 Primary ICEfx Cryoablation System K181153 Reference The design, funct…
Eigen2016—
*K0810933-D Imaging Workstation
Summary page 9
…Primary Predicate Device: Eigen, LLC Reference Predicate Device: ICEfx Eigen 3-D Imaging Workstation K081093 Cryoablation System (K181153) Artemis Intended Use Artemis along with the Needle Guide Artemis alo…
Eigen, LLC2008—
†K181153ICEfx Cryoablation SystemGalil Medical, Inc.2018—

Also cleared against K162474: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 27 years and passes through 6 companies; a new generation was cleared every 2.5 years on median.
  • 2 of the 12 ancestors have a recall of any class.
  • 1 other device also cites its predicate K162474.

How does its category compare?

All QTZ devices

QTZ Radiological Image Processing Software For Ablation Therapy Planning And Evaluation: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · QTZ

1in 2025

2022: 12023: 32024: 22025: 12026 (partial year): 2
2007high 3 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QTZ

351in 2023

2023: 351 days median
2007high 351 (2023)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QTZ

No recall names QTZ since 2007.

Adverse event reports per year · QTZ

No MAUDE report names QTZ since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20221—00
2023335100
20242—00
20251—00
20262—0—

What is it indicated for?

Artemis along with the Needle Guide Attachment is used for image-guided interventional and diagnostic procedures of the prostate gland. It provides 2D and 3D visualization of Ultrasound (US) images and the ability to fuse and register these images with those from other imaging modalities such as Ultrasound, Magnetic Resonance, Computed Tomography, etc. It also provides the ability to display a simulated image of a tracked insertion tool such as a biopsy…

Read the full statement (337 words)

Artemis along with the Needle Guide Attachment is used for image-guided interventional and diagnostic procedures of the prostate gland. It provides 2D and 3D visualization of Ultrasound (US) images and the ability to fuse and register these images with those from other imaging modalities such as Ultrasound, Magnetic Resonance, Computed Tomography, etc. It also provides the ability to display a simulated image of a tracked insertion tool such as a biopsy needle, guidewire or probe on a computer monitor screen that shows images of the target organ and the current and the projected future path of the interventional instrument taking into account patient movement. The software also provides a virtual grid on the live ultrasound for performing systematic sampling of the target organ. Other software features include patient data management, multi-planar reconstruction, segmentation, image measurements, 2D/3D image registration, reporting, and pathology management.

Artemis is intended for treatment planning and guidance for clinical, interventional and/or diagnostic procedures. The device is intended to be used in interventional and diagnostic procedures in a clinical setting. Example procedures include, but are not limited to image fusion for diagnostic clinical examinations and procedures, soft tissue biopsies, soft tissue ablations and placement of fiducial markers. Artemis is also intended to be used for patients in active surveillance to keep track of previous procedures information and outcomes.

Artemis Cryo Treatment Planning module is an add on to the existing Artemis software that allows physicians to prepare for cryo treatment planning based on positive pathology cores obtained during Artemis guided biopsies and registration results with other imaging modalities such as MRI, CT. The module allows accurate placement of cryo probes on targets, 3D tracking, real-time feedback on extend of cryo ice formation. The technology provided by Artemis generates ice models based on the specifications provided by the cryo device manufacturers and displays the models on the live ultrasound to provide guidance to the users during the procedure.

The module also allows outlining or segmenting other organs that surround the prostate. Organs include bladder and urethra.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K222222: Artemis, Artemis TPO, Artemis MX.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K222222

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026